Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Fortress Biotech, Inc. | Chief Financial Officer | Common Stock, par value $0.001 | 164K | $389K | $2.38 | Sep 21, 2021 | Direct |
TENAX THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 100K | Dec 10, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TENX | TENAX THERAPEUTICS, INC. | Dec 10, 2024 | 1 | $0 | 4 | Dec 12, 2024 | Director |
TENX | TENAX THERAPEUTICS, INC. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
TENX | TENAX THERAPEUTICS, INC. | Jan 28, 2022 | 0 | $0 | 3 | Jan 31, 2022 | Director |
FBIO | Fortress Biotech, Inc. | Sep 21, 2021 | 1 | -$88.6K | 4 | Apr 29, 2022 | Chief Financial Officer |